Cochrane · systematic review · CD003617
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
Koretz, RL, Pleguezuelo, M, Arvaniti, V, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
0
No studies
2
Included studies
NR
No studies 2 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings ‐ hepatic morbidity
Population: patients with chronic hepatitis C who have failed prior antiviral therapy and who have severe histologic disease (grade 3 or 4 fibrosis) but compensated liver disease.
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Variceal bleeding 5 years | no estimate extracted | NR | No studies |
Ascites 5 years | no estimate extracted | NR | No studies |